These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 18608912)
101. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia. Becerra-Álvarez P; Escandón P; Lizarazo J; Quirós-Gómez Ó; Firacative C Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36066645 [TBL] [Abstract][Full Text] [Related]
102. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Lortholary O; Improvisi L; Rayhane N; Gray F; Fitting C; Cavaillon JM; Dromer F Infect Immun; 1999 Dec; 67(12):6314-20. PubMed ID: 10569743 [TBL] [Abstract][Full Text] [Related]
104. Induction of protective immunity against cryptococcosis. Wozniak KL; Hardison S; Olszewski M; Wormley FL Mycopathologia; 2012 Jun; 173(5-6):387-94. PubMed ID: 22143898 [TBL] [Abstract][Full Text] [Related]
105. Detection of antibody against fungal glucosylceramide in immunocompromised patients: a potential new diagnostic approach for cryptococcosis. Qureshi A; Wray D; Rhome R; Barry W; Del Poeta M Mycopathologia; 2012 Jun; 173(5-6):419-25. PubMed ID: 21971701 [TBL] [Abstract][Full Text] [Related]
106. [Serological tests for diagnosing fungal infections]. Lass-Flörl C Wien Med Wochenschr; 2007; 157(19-20):526-9. PubMed ID: 18030559 [TBL] [Abstract][Full Text] [Related]
115. Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome. Ssebambulidde K; Anjum SH; Hargarten JC; Chittiboina P; Shoham S; Seyedmousavi S; Marr KA; Hammoud DA; Billioux BJ; Williamson PR Front Neurol; 2022; 13():994396. PubMed ID: 36530631 [TBL] [Abstract][Full Text] [Related]
116. Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients. Gressler AE; Volke D; Firacative C; Schnabel CL; Müller U; Krizsan A; Schulze-Richter B; Brock M; Brombacher F; Escandón P; Hoffmann R; Alber G Front Immunol; 2021; 12():709695. PubMed ID: 34367172 [No Abstract] [Full Text] [Related]
117. Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis. Saha DC; Xess I; Zeng WY; Goldman DL Med Mycol; 2008 Aug; 46(5):457-63. PubMed ID: 18608912 [TBL] [Abstract][Full Text] [Related]
118. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection. Abadi J; Pirofski La J Infect Dis; 1999 Sep; 180(3):915-9. PubMed ID: 10438394 [TBL] [Abstract][Full Text] [Related]
119. Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting. Lamura L; Matthews RC; Barchiesi F; Donahoe M; Burnie JP; Scalise G J Infect; 2000 Jan; 40(1):64-8. PubMed ID: 10762114 [TBL] [Abstract][Full Text] [Related]
120. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Zhang H; Zhong Z; Pirofski LA Infect Immun; 1997 Apr; 65(4):1158-64. PubMed ID: 9119446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]